Intensity Therapeutics raises $6.6M via ATM stock sales; cash runway extended to H2 2026

INTENSITY THERAPEUTICS, INC.

Gross proceeds of $6.6M ($6.3M net) from sale of 19,868,658 shares at avg $0.3323/share in July 2025.
Shares outstanding post-ATM: 46,035,081 as of July 31, 2025.
Average price per share >10% higher than June 2025 public offering, reducing dilution cost.
Proceeds extend cash runway into second half of 2026 to advance clinical trials.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.